Search Results 81-90 of 18481 for total bilirubin

1. Study Using Chromogranin A As Surveillance Biomarker In Patients With CARcinoids - Mayo Clinic

   Severe liver dysfunction in the absence of liver metastasis defined by aspartate aminotransferase (AST), serum total bilirubin and/or alanine transaminase ...

2. Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer - Mayo Clinic

   - Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN) (except patients ... [SGOT])/alanine aminotransferase (ALT) (serum glutamate pyruvate ...

3. Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 - Mayo Clinic

   - Total bilirubin greater than ULN (upper limit of normal) for the lab or greater than 1.5 x ULN for patients who have a bilirubin elevation due to ...

4. Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors - Mayo Clinic

   ... serum alpha-fetoprotein (AFP) > 400 ng/ml ... bilirubin =< 1.5 x ULN (institutional upper limit ... Total abstinence from sexual intercourse (minimum ...

5. A Study To Evaluate The Safety And Efficacy Of Ombitasvir/ABT-450/Ritonavir And Dasabuvir In Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection And Cirrhosis - Mayo Clinic

   Total bilirubin > 3.0 mg/dL. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to-date ...

6. A Study to Evaluate PDS0101 and Pembrolizumab Combination to Treat Subjects with HPV16 + Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

   institutional ULN; Hepatic: Total bilirubin ≤1.5 × ULN or direct bilirubin ≤ULN for subjects with total bilirubin levels >1.5 × ULN, AST and ALT ≤2.5 ULN ...

7. Emricasan, A Caspase Inhibitor, For Evaluation In Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis - Mayo Clinic

   ... bilirubin >1.5 times ULN during screening (unless subject has elevated total bilirubin due to Gilbert's as documented in the medical records); Alpha ...

8. Dose-Escalation Study of cevostamab (BFCR4350A) in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM) - Mayo Clinic

   ... total bilirubin elevations are accompanied by elevated indirect bilirubin are eligible. Hematologic function (requirement prior to first dose of cevostamab):.

9. Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma - Mayo Clinic

   - Total bilirubin =< 2.0 times the upper limit of the institutional normal values except in subjects with congenital bilirubinemia, such as Gilbert syndrome ...

10. Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer - Mayo Clinic

    Total bilirubin ≤ 1.5 x upper limit of normal (ULN). Aspartate transaminase (AST) and/or alanine transaminase (ALT) ≤ 2.5 x ULN or ≤ 5 x ULN for patients ...